Elicio Therapeutics ELTX
NASDAQ ELTX
$1.94 +0.27 (+16.17%)
At close: Oct 22, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Non Operating Interest Expenses (2022 - 2026)

Updated

Elicio Therapeutics' Non Operating Interest Expenses was $410,000 in Q2 2026, up 111.3% from $194,000 a year earlier and up 0.7% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Elicio Therapeutics' Non Operating Interest Expenses was $1.58 million through Jun 30, 2026, up 113.2% year-over-year; for FY2025, it came in at $1.13 million, up 149.0% from FY2024.

  • Non Operating Interest Expenses shows a three-year compound annual growth rate of -32.0% (FY2022 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $455,000 in FY2024 (-57.0%), $1.06 million in FY2023 (-70.6%) and $3.6 million in FY2022.
  • Quarterly Non Operating Interest Expenses has moved between $1,000 (Q3 2023) and $1.08 million (Q3 2022) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses has increased for six straight quarters, with growth averaging 197.1% over the last six quarters.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q1 2025 (growth of 388.9%); the worst was Q3 2023 (a decline of 99.9%).
  • Per Business Quant data, ELTX's Non Operating Interest Expenses in the three quarters before Q2 2026 was $407,000 (Q1 2026), $337,000 (Q4 2025) and $426,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Elicio Therapeutics 36.93 Mn -40.70 Mn - 410,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 410,000.00
Mar 31, 2026 407,000.00
Dec 31, 2025 337,000.00
Sep 30, 2025 426,000.00
Jun 30, 2025 194,000.00
Mar 31, 2025 176,000.00
Dec 31, 2024 234,000.00
Sep 30, 2024 137,000.00
Jun 30, 2024 49,000.00
Mar 31, 2024 36,000.00
Dec 31, 2023 2,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 714,000.00
Mar 31, 2023 342,000.00
Dec 31, 2022 92,000.00
Sep 30, 2022 1.08 Mn
Jun 30, 2022 1.07 Mn
API Access

Elicio Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ELTX&period=max&api_key=YOUR_API_KEY